New Zealand markets close in 6 hours

1 Green Flag for Moderna's Fall Vaccine Plan, and 1 Red Flag

·3-min read

Moderna (NASDAQ: MRNA) took center stage when it launched its coronavirus vaccine about a year and a half ago. Moderna recently reported that its booster candidate offers "superior" performance against the omicron variant.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting